28 September is the International Day for Universal Access to Information.
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
September 28, 2026 at 11:59 AM
28 September is the International Day for Universal Access to Information.
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
Community input is key to #LONGEVITYproject.
Patients were enthusiastic for long-acting therapeutics, but highlighted two concerns:
💊Will they be as effective as daily pills?
💉Will side effects last longer?
We spoke to Prof Susan Swindells from @unmc.bsky.social
www.liverpool.ac.uk/celt-global-...
Patients were enthusiastic for long-acting therapeutics, but highlighted two concerns:
💊Will they be as effective as daily pills?
💉Will side effects last longer?
We spoke to Prof Susan Swindells from @unmc.bsky.social
www.liverpool.ac.uk/celt-global-...
August 27, 2026 at 11:54 AM
Community input is key to #LONGEVITYproject.
Patients were enthusiastic for long-acting therapeutics, but highlighted two concerns:
💊Will they be as effective as daily pills?
💉Will side effects last longer?
We spoke to Prof Susan Swindells from @unmc.bsky.social
www.liverpool.ac.uk/celt-global-...
Patients were enthusiastic for long-acting therapeutics, but highlighted two concerns:
💊Will they be as effective as daily pills?
💉Will side effects last longer?
We spoke to Prof Susan Swindells from @unmc.bsky.social
www.liverpool.ac.uk/celt-global-...
We send a quarterly newsletter about recent #LONGEVITYproject work.
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
August 17, 2026 at 11:30 AM
We send a quarterly newsletter about recent #LONGEVITYproject work.
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
For #WorldHepatitisDay we spoke to Dr Usman Arshad about this year's CROI, where he discussed the co-formulation aspect of our proof-of-concept one-shot-cure options for hepatitis C virus.
Find out more in: www.liverpool.ac.uk/celt-global-...
The #LONGEVITYproject is funded by @unitaid.bsky.social
Find out more in: www.liverpool.ac.uk/celt-global-...
The #LONGEVITYproject is funded by @unitaid.bsky.social
July 28, 2026 at 12:09 PM
For #WorldHepatitisDay we spoke to Dr Usman Arshad about this year's CROI, where he discussed the co-formulation aspect of our proof-of-concept one-shot-cure options for hepatitis C virus.
Find out more in: www.liverpool.ac.uk/celt-global-...
The #LONGEVITYproject is funded by @unitaid.bsky.social
Find out more in: www.liverpool.ac.uk/celt-global-...
The #LONGEVITYproject is funded by @unitaid.bsky.social
Still wondering what the #LONGEVITYproject is?
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
The LONGEVITY Project
YouTube video by CELT Liverpool
youtu.be
July 6, 2026 at 11:19 AM
Still wondering what the #LONGEVITYproject is?
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
Are you signed up to the #LONGEVITYproject newsletter?
A quarterly news, events and opportunities update from LONGEVITY - a group working on long-acting preventatives of TB and malaria, and a one-shot-cure for HCV for people in LMICs
www.liverpool.ac.uk/celt-global-...
Funded by @unitaid.bsky.social
A quarterly news, events and opportunities update from LONGEVITY - a group working on long-acting preventatives of TB and malaria, and a one-shot-cure for HCV for people in LMICs
www.liverpool.ac.uk/celt-global-...
Funded by @unitaid.bsky.social
June 18, 2026 at 11:26 AM
Are you signed up to the #LONGEVITYproject newsletter?
A quarterly news, events and opportunities update from LONGEVITY - a group working on long-acting preventatives of TB and malaria, and a one-shot-cure for HCV for people in LMICs
www.liverpool.ac.uk/celt-global-...
Funded by @unitaid.bsky.social
A quarterly news, events and opportunities update from LONGEVITY - a group working on long-acting preventatives of TB and malaria, and a one-shot-cure for HCV for people in LMICs
www.liverpool.ac.uk/celt-global-...
Funded by @unitaid.bsky.social
To make this happen takes more than creating a medicine, it requires community input and advocacy from the beginning, licencing expertise and regulatory liaison.
The #LONGEVITYproject is an international consortium that covers all these areas.
The #LONGEVITYproject is an international consortium that covers all these areas.
June 4, 2026 at 11:14 AM
To make this happen takes more than creating a medicine, it requires community input and advocacy from the beginning, licencing expertise and regulatory liaison.
The #LONGEVITYproject is an international consortium that covers all these areas.
The #LONGEVITYproject is an international consortium that covers all these areas.
To make this happen takes more than creating a medicine, it requires community input and advocacy from the beginning, licencing expertise and regulatory liaison.
The #LONGEVITYproject is an international consortium that covers all these areas.
The #LONGEVITYproject is an international consortium that covers all these areas.
May 7, 2026 at 11:29 AM
To make this happen takes more than creating a medicine, it requires community input and advocacy from the beginning, licencing expertise and regulatory liaison.
The #LONGEVITYproject is an international consortium that covers all these areas.
The #LONGEVITYproject is an international consortium that covers all these areas.
Just after #WorldLiverDay, we're excited a #LONGEVITYproject Community Advisory Board member is presenting ‘Surveys on preferences and feasibility of long-acting technologies for the treatment of Hepatitis C Virus’ at the World Hepatitis Summit next week.
www.liverpool.ac.uk/celt-global-...
www.liverpool.ac.uk/celt-global-...
April 21, 2026 at 11:10 AM
Just after #WorldLiverDay, we're excited a #LONGEVITYproject Community Advisory Board member is presenting ‘Surveys on preferences and feasibility of long-acting technologies for the treatment of Hepatitis C Virus’ at the World Hepatitis Summit next week.
www.liverpool.ac.uk/celt-global-...
www.liverpool.ac.uk/celt-global-...
We have a page for each of the #LONGEVITYproject diseases that explains:
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
April 2, 2026 at 11:30 AM
We have a page for each of the #LONGEVITYproject diseases that explains:
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
🧵2/2
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
March 18, 2026 at 1:13 PM
🧵2/2
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
🧵1/2
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
March 18, 2026 at 1:12 PM
🧵1/2
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
📣We received the @sciupdate.bsky.social Formulation Forum Innovation Runner Up Award!
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
March 12, 2026 at 2:47 PM
📣We received the @sciupdate.bsky.social Formulation Forum Innovation Runner Up Award!
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
March 9, 2026 at 4:15 PM
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
#LONGEVITYproject is a consortium researching long-acting malaria and TB preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
March 3, 2026 at 12:01 PM
#LONGEVITYproject is a consortium researching long-acting malaria and TB preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
February 17, 2026 at 2:58 PM
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
#February11
@unitaid.bsky.social
February 11, 2026 at 2:38 PM
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
#February11
@unitaid.bsky.social
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
February 6, 2026 at 12:45 PM
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
January 21, 2026 at 12:02 PM
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
We've compiled what 2025 looked like for the #LONGEVITYproject.
The achievements and news get us closer to our goal to bring long-acting preventatives/treatments for malaria, TB and hepatitis C to patients in LMICs where the need is greatest.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The achievements and news get us closer to our goal to bring long-acting preventatives/treatments for malaria, TB and hepatitis C to patients in LMICs where the need is greatest.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
December 18, 2025 at 12:12 PM
We've compiled what 2025 looked like for the #LONGEVITYproject.
The achievements and news get us closer to our goal to bring long-acting preventatives/treatments for malaria, TB and hepatitis C to patients in LMICs where the need is greatest.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The achievements and news get us closer to our goal to bring long-acting preventatives/treatments for malaria, TB and hepatitis C to patients in LMICs where the need is greatest.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Are you signed up to the quarterly #LONGEVITYproject newsletter?
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 25, 2025 at 1:02 PM
Are you signed up to the quarterly #LONGEVITYproject newsletter?
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 19, 2025 at 12:19 PM
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
October 23, 2025 at 11:53 AM
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
September 24, 2025 at 12:23 PM
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
17 September is #InternationalMicroorganismDay and @who.int's #PatientSafetyDay
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
September 17, 2025 at 11:49 AM
17 September is #InternationalMicroorganismDay and @who.int's #PatientSafetyDay
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...